For: | Wu ST, Zhu L, Feng XL, Wang HY, Li F. Strategies for discovering novel hepatocellular carcinoma biomarkers. World J Hepatol 2025; 17(2): 101201 [PMID: 40027561 DOI: 10.4254/wjh.v17.i2.101201] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v17/i2/101201.htm |
Number | Citing Articles |
1 |
Xu Chenzhou, Shen Fei. Coiled-coil-helix-coiled-coil-helix Domain Containing 1 Promotes Hepatocellular Carcinoma Progression by Regulating Transforming Growth Factor Beta Receptor 1 in the Tumor Immune Microenvironment. Genetic Testing and Molecular Biomarkers 2025; doi: 10.1177/19450265251384161
|
2 |
William Yang, Romario Nguyen, Fatema Safri, Muhammad J. A. Shiddiky, Majid E. Warkiani, Jacob George, Liang Qiao. Liquid Biopsy in Hepatocellular Carcinoma: ctDNA as a Potential Biomarker for Diagnosis and Prognosis. Current Oncology Reports 2025; 27(6): 791 doi: 10.1007/s11912-025-01681-3
|
3 |
Min Xu, Tian-Tian Ruan, Hao Tang, Rong-Fei Fang, Wen-Li Sai, Qun Xie, Deng-Fu Yao, Min Yao. Up-regulated programmed cell death protein-1/its ligand 1 expression promotes metabolic dysfunction-associated steatotic liver disease malignant progression. World Journal of Gastrointestinal Oncology 2025; 17(5): 104842 doi: 10.4251/wjgo.v17.i5.104842
|